XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Stock-Based Compensation  
Schedule of stock-based compensation expense

Stock-based compensation expense as reflected in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three months ended
September 30,

​

Nine months ended
September 30, 

​

    

2024

    

2023

​

2024

    

2023

Research and development

​

$

327

​

$

184

​

$

867

​

$

485

General and administrative

​

 

827

​

 

659

​

 

2,236

​

 

2,566

Stock-based compensation expense included in operating expenses

​

$

1,154

​

$

843

​

$

3,103

​

$

3,051

Summary of stock option activity

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2024:

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted- 

    

Weighted- average 

    

Aggregate 

​

​

​

​

average 

​

remaining contractual 

​

intrinsic value

​

​

Options

​

exercise price

​

term (in years)

​

(in thousands)

Outstanding at December 31, 2023

 

4,178,194

​

$

2.98

 

8.22

​

$

11

Granted

 

2,702,050

​

​

2.94

 

​

​

 

​

Exercised

​

(379,425)

​

​

1.31

​

​

​

​

​

Cancelled

​

(251,931)

​

​

4.43

​

​

​

​

​

Outstanding at September 30, 2024

 

6,248,888

​

$

3.01

 

4.44

​

$

2

Vested at September 30, 2024

​

2,607,444

​

$

3.54

​

​

​

$

—

Vested and expected to vest at September 30, 2024

 

6,248,888

​

$

3.01

 

4.44

​

$

2

​

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2023:

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

Weighted- 

    

Weighted- average 

    

Aggregate 

​

​

​

​

average 

​

remaining contractual 

​

intrinsic value

​

​

Options

​

exercise price

​

term (in years)

​

(in thousands)

Outstanding at December 31, 2022

 

4,408,274

​

$

3.44

 

8.52

​

$

350

Granted

 

2,367,139

​

​

1.10

 

​

​

 

​

Exercised

​

(1,264,899)

​

​

1.18

​

​

​

​

​

Cancelled

​

(1,074,995)

​

​

2.67

​

​

​

​

​

Outstanding at September 30, 2023

 

4,435,519

​

$

3.02

 

8.48

​

$

25

Vested at September 30, 2023

​

2,807,686

​

$

3.27

​

5.55

​

$

22

Vested and expected to vest at September 30, 2023

 

4,435,519

​

$

3.02

 

8.48

​

$

25

​

Schedule of assumptions used in estimation of fair value

​

​

​

​

​

​

​

​

​

​

​

​

    

Three months ended September 30, 

 

​

Nine months ended September 30, 

 

​

​

2024

    

2023

 

​

2024

    

2023

 

Risk-free interest rate

 

3.46 - 4.15

%  

4.02 - 4.20

%

​

3.46 - 4.65

%  

3.67 - 4.24

%

Volatility

 

75 - 76

%  

72 - 73

%

​

72 - 76

%  

72 - 74

%

Dividend yield

 

0.00

%  

0.00

%

​

0.00

%  

0.00

%

Expected term (years)

 

6

 

6

​

​

6 - 7

 

2 - 7

​

Summary of restricted stock units activity

The following table summarizes activity related to RSUs:

​

​

​

​

​

​

​

    

​

    

Weighted- average

​

​

​

​

grant date

​

​

Number of shares

​

fair value

Unvested at December 31, 2023

 

155,797

​

$

8.25

Granted

 

437,025

​

$

2.77

Vested

​

(66,589)

​

$

9.48

Cancelled

​

(27,400)

​

$

2.28

Unvested at September 30, 2024

 

498,833

​

$

3.61